生育治療服務市場規模、佔有率和成長分析(按手術、服務、最終用戶和地區分類)-2026-2033年產業預測
市場調查報告書
商品編碼
1902486

生育治療服務市場規模、佔有率和成長分析(按手術、服務、最終用戶和地區分類)-2026-2033年產業預測

Fertility Services Market Size, Share, and Growth Analysis, By Procedure (IVF with ICSI, IVF without ICSI), By Service (Fresh Non-Donor, Frozen Non-Donor), By End User, By Region -Industry Forecast 2026-2033

出版日期: | 出版商: SkyQuest | 英文 196 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

預計到 2024 年,不孕症治療服務市場規模將達到 477.4 億美元,到 2025 年將達到 519.9 億美元,到 2033 年將達到 1028.4 億美元,預測期(2026-2033 年)的複合年成長率為 8.9%。

市場趨勢分析顯示,受社會規範變化的影響,對生育治療服務的需求顯著成長。由於越來越多的女性因事業或個人原因而延遲生育,初次生育的平均年齡不斷上升,導致不孕率上升。研究表明,這一趨勢在已開發國家尤其明顯,許多女性面臨自然受孕困難。因此,隨著夫妻尋求有效解決生育難題的途徑,對輔助生殖技術(ART)的需求明顯增加。生活方式選擇與生物因素之間的複雜相互作用,進一步加劇了對各種輔助生殖技術服務的需求。隨著社會動態的不斷演變,生育治療服務市場預計將持續成長,以滿足未來父母日益成長的需求。

生育治療服務市場的成長要素

生育服務市場的成長主要受不孕症上升的驅動,而不孕不育的成因包括壓力增加、生育計畫延遲、生活方式改變等。此外,肥胖、吸菸等健康問題以及環境毒素暴露也加劇了許多人的生殖健康挑戰。為了滿足日益成長的有效解決方案需求,輔助生殖技術(ART)的進步顯著提高了現有治療的品質和有效性,為渴望生育的人們帶來了希望。這種不斷變化的市場格局凸顯了提供全面生育服務以應對複雜生殖健康問題的迫切需求。

生育治療服務市場的限制

生育服務市場面臨許多限制因素,這些限制因素源自於與生殖技術相關的道德和法律挑戰。胚胎冷凍、代孕和卵子捐贈等程序在不同地區常常遭遇宗教和文化上的反對。此外,各國不同的法律體制也構成障礙,限制了人們獲得這些治療的機會,阻礙了輔助生殖技術的廣泛應用。這些差異不僅影響尋求生育治療的個人,也導致市場格局分散,使得服務提供者難以應對在全球範圍內提供服務的複雜性。

不孕症治療服務的市場趨勢

生育服務市場正經歷一個顯著的趨勢:生育力保存技術的普及率不斷提高,尤其是在千禧世代和麵臨健康挑戰的人群中。隨著越來越多的人出於個人、職業和健康原因推遲生育,對卵子和精子冷凍保存等服務的需求也隨之激增。這種轉變推動了冷凍保存技術的進步,並有助於提高人們獲得生殖健康服務的機會。此外,輔助生殖技術的社會接受度不斷提高,也為尋求這些服務的個人創造了有利的環境,最終促進了生育服務產業的蓬勃發展和創新。

目錄

介紹

  • 調查目標
  • 調查範圍
  • 定義

調查方法

  • 資訊收集
  • 二手資料和一手資料方法
  • 市場規模預測
  • 市場假設與限制

執行摘要

  • 全球市場展望
  • 供需趨勢分析
  • 細分市場機會分析

市場動態與展望

  • 市場規模
  • 市場動態
    • 促進因素和機遇
    • 限制與挑戰
  • 波特分析

關鍵市場考察

  • 關鍵成功因素
  • 競爭程度
  • 關鍵投資機會
  • 市場生態系統
  • 市場吸引力指數(2025)
  • PESTEL 分析
  • 總體經濟指標
  • 價值鏈分析
  • 定價分析
  • 案例研究
  • 監管環境

全球不孕症治療服務市場規模(按類型及複合年成長率分類)(2026-2033 年)

  • 診斷
  • 治療
  • 保持

全球不孕症治療服務市場規模(依治療項目及複合年成長率分類)(2026-2033 年)

  • 體外受精(IVF)結合卵胞漿內單一精子注射(ICSI)
  • 子宮內人工授精(IUI)
  • 體外受精(IVF)無需卵胞漿內單一精子注射(ICSI)。
  • 代孕
  • 其他治療方法

全球不孕症治療服務市場規模(按服務類型分類)及複合年成長率(2026-2033 年)

  • 新鮮非提供者
  • 冷凍非捐贈者
  • 卵子和胚胎庫
  • 新捐贈者
  • 冷凍捐贈者

全球不孕症治療服務市場規模(依最終用戶分類)及複合年成長率(2026-2033 年)

  • 不孕不育診所
  • 醫院
  • 手術中心
  • 臨床研究所

全球不孕症治療服務市場規模及複合年成長率(2026-2033)

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 西班牙
    • 法國
    • 英國
    • 義大利
    • 其他歐洲地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地區
  • 中東和非洲
    • 海灣合作理事會國家
    • 南非
    • 其他中東和非洲地區

競爭資訊

  • 前五大公司對比
  • 主要企業的市場定位(2025 年)
  • 主要市場參與者所採取的策略
  • 近期市場趨勢
  • 公司市佔率分析(2025 年)
  • 主要企業公司簡介
    • 公司詳情
    • 產品系列分析
    • 依業務板塊進行公司股票分析
    • 2023-2025年營收年比比較

主要企業簡介

  • Merck KGaA(Germany)
  • Vitrolife AB(Sweden)
  • Monash IVF Group(Australia)
  • Genea Limited(Australia)
  • Progyny, Inc.(United States)
  • Ferring Pharmaceuticals(Switzerland)
  • CooperSurgical, Inc.(United States)
  • Cook Medical Inc.(United States)
  • The Cooper Companies, Inc.(United States)
  • Virtus Health(Australia)
  • Cryos International(Denmark)
  • Carolinas Fertility Institute(United States)
  • Apollo Fertility(India)
  • Bloom IVF Centre(India)
  • Bangkok IVF Center(Thailand)
  • Medicover Fertility(Sweden)

結論與建議

簡介目錄
Product Code: SQMIG35D2292

Fertility Services Market size was valued at USD 47.74 Billion in 2024 and is poised to grow from USD 51.99 Billion in 2025 to USD 102.84 Billion by 2033, growing at a CAGR of 8.9% during the forecast period (2026-2033).

Market insights reveal a notable surge in the demand for fertility services, driven by shifts in societal norms. With women increasingly delaying motherhood for career advancements and personal goals, the median age for first-time mothers has risen, contributing to heightened infertility rates. Studies indicate this trend is particularly evident in developed countries, where many women are experiencing difficulties in conceiving naturally. Consequently, the rising demand for Assisted Reproductive Technology (ART) is evident, as couples seek effective solutions for conception challenges. The complex interplay of lifestyle choices and biological factors amplifies the necessity for a diverse range of ART services. As societal dynamics continue to evolve, the fertility services market is poised for sustained growth to meet the burgeoning needs of prospective parents.

Top-down and bottom-up approaches were used to estimate and validate the size of the Fertility Services market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Fertility Services Market Segments Analysis

Global Fertility Services Market is segmented by Type, Procedure, Service, End-User and region. Based on Type, the market is segmented into Diagnosis, Treatment and Preservation. Based on Procedure, the market is segmented into In Vitro Fertilization (IVF) with Intracytoplasmic Sperm Injection (ICSI), Intrauterine Insemination (IUI), IVF without ICSI, Surrogacy and Other Procedures. Based on Service, the market is segmented into Fresh Non-donor, Frozen Non-donor, Egg & Embryo Banking, Fresh Donor and Frozen Donor. Based on End-User, the market is segmented into Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Fertility Services Market

The growth of the fertility services market is largely attributed to rising infertility rates influenced by factors such as heightened stress levels, delayed family planning, and changing lifestyles. Furthermore, health issues like obesity and smoking, along with exposure to environmental toxins, have increased reproductive health challenges for many individuals. In response to this growing demand for effective solutions, advancements in assisted reproductive technology (ART) have significantly enhanced the quality and effectiveness of treatments available, providing hope to those seeking to conceive. This evolving landscape underscores the urgent need for comprehensive fertility services to address the complexities surrounding reproductive health.

Restraints in the Fertility Services Market

The Fertility Services market faces several constraints rooted in moral and legal challenges associated with reproductive technologies. Practices such as embryo freezing, surrogacy, and egg donation often encounter significant religious and cultural opposition in various regions. Additionally, varying legal frameworks across countries can create barriers that limit access to these treatments, hindering the widespread acceptance of assisted reproductive technologies. Such disparities not only impact individuals seeking fertility assistance but also contribute to a fragmented market landscape, making it difficult for providers to navigate the complexities of offering services in a global context.

Market Trends of the Fertility Services Market

The fertility services market is witnessing a significant trend driven by the rising adoption of fertility preservation techniques, particularly among millennials and individuals facing medical challenges. As more people delay parenthood for personal, professional, or health-related reasons, the demand for services such as egg and sperm freezing is surging. This shift is catalyzing advancements in cryopreservation technologies and enhancing overall accessibility to fertility options. Additionally, the cultural acceptance of assisted reproductive technologies is fostering a supportive environment for individuals seeking these services, ultimately contributing to robust growth and innovation in the fertility services sector.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2025
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Case Studies
  • Regulatory Landscape

Global Fertility Services Market Size by Type & CAGR (2026-2033)

  • Market Overview
  • Diagnosis
  • Treatment
  • Preservation

Global Fertility Services Market Size by Procedure & CAGR (2026-2033)

  • Market Overview
  • In Vitro Fertilization (IVF) with Intracytoplasmic Sperm Injection (ICSI)
  • Intrauterine Insemination (IUI)
  • IVF without ICSI
  • Surrogacy
  • Other Procedures

Global Fertility Services Market Size by Service & CAGR (2026-2033)

  • Market Overview
  • Fresh Non-donor
  • Frozen Non-donor
  • Egg & Embryo Banking
  • Fresh Donor
  • Frozen Donor

Global Fertility Services Market Size by End-User & CAGR (2026-2033)

  • Market Overview
  • Fertility Clinics
  • Hospitals
  • Surgical Centers
  • Clinical Research Institutes

Global Fertility Services Market Size & CAGR (2026-2033)

  • North America (Type, Procedure, Service, End-User)
    • US
    • Canada
  • Europe (Type, Procedure, Service, End-User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Type, Procedure, Service, End-User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Type, Procedure, Service, End-User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Type, Procedure, Service, End-User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

  • Merck KGaA (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Vitrolife AB (Sweden)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Monash IVF Group (Australia)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Genea Limited (Australia)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Progyny, Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Ferring Pharmaceuticals (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CooperSurgical, Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cook Medical Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • The Cooper Companies, Inc. (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Virtus Health (Australia)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cryos International (Denmark)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Carolinas Fertility Institute (United States)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Apollo Fertility (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bloom IVF Centre (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bangkok IVF Center (Thailand)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medicover Fertility (Sweden)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations